Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders
Clinical trial NCT06333652 · RECRUITING
Trial details
- NCT number
- NCT06333652
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2028-12-31
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.